Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can vibration or gravity training help children with muscular dystrophy stand stronger?

NCT ID NCT07780435

Disease control Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This trial asks whether whole-body vibration or gravity-force stimulation can better improve postural stability in children with Duchenne muscular dystrophy (DMD). It will include 60 children aged 6 to 10 who can walk independently. The study compares two exercise-based approaches to see which one may help strengthen trunk and balance control.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
whole-body vibration and gravity-force stimulation
What this could lead to
If effective, these therapies could offer new ways to improve balance and trunk stability in children with Duchenne muscular dystrophy, potentially enhancing mobility and quality of life.
What could go wrong
This is a small, early-stage trial, and results may not be conclusive or widely applicable. The therapies are supportive and not a cure, and individual responses may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Apr 2026

Finished

Aug 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 10 years

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children diagnosed with Duchenne Muscular Dystrophy (DMD). * Age between 6 and 10 years. * Lower extremity and trunk muscle strength graded at least 3+, based on the manual muscle testing criteria. * Ability to move the upper and lower limbs within functional limits without severe joint restriction. * Ability to walk independently without assistive devices, corresponding to Levels I and II of the Ambulation Function Classification System for DMD (AFCSD). Exclusion Criteria: * Presence of cardiopulmonary dysfunction or congenital or acquired skeletal abnormalities that may interfere with participation. * History of lower-limb surgical procedures. * Neurological conditions affecting balance or gait, or evidence of poor motor development not attributable to DMD. * Behavioral disorders that would prevent cooperation during assessment or intervention sessions. * Overweight status, defined as a body mass index (BMI) greater than 25 kg/m²

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Duchene muscular dystrophy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Duchenne muscular dystrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Duchene muscular dystrophy

Contacts and locations

Locations

  • Cairo university

    Giza, Giza Governorate, 11432, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.